| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000025075 |
| Receipt No. | R000028843 |
| Scientific Title | Effects of early enteral nutrition in acute stroke patients: an open-label randomized study |
| Date of disclosure of the study information | 2016/12/01 |
| Last modified on | 2020/12/03 (Ver. 2) |
| Basic information | ||
| Public title | Effects of early enteral nutrition in acute stroke patients: an open-label randomized study | |
| Acronym | Early enteral nutrition in acute stroke patients | |
| Scientific Title | Effects of early enteral nutrition in acute stroke patients: an open-label randomized study | |
| Scientific Title:Acronym | Early enteral nutrition in acute stroke patients | |
| Region |
|
|
| Condition | ||
| Condition | Stroke | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effects of early enteral feeding on systemic inflammation in acute stroke patients |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Changes of the serum levels of inflammatory markers (interleukin-6, high sensitivity CRP) , LPS binding protein and an intestinal permeability marker (zonulin) from the first to seventh and fourteenth feeding days. |
| Key secondary outcomes | Frequency of infection
National institute of health stroke scale Modified Rankin Scale |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Early enteral nutrition via a nasogastric tube with an oligomeric formula containing hydrolyzed whey protein within 24 hours after admission. | |
| Interventions/Control_2 | Enteral nutrition with a polymeric formula via a nasogastric tube. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Stroke patients within 24 hours from onset.
2. An inadequate or unsafe oral intake. |
|||
| Key exclusion criteria | 1. Use of antibiotics within 3 months
2. Infection at admission 3. Malignant tumor 4. Autoimmune diseases 5. Postoperative state due to gastrointestinal disorders 6. Liver or renal failure 7. Poorly controlled diabetes |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Juntendo University School of Medicine | ||||||
| Division name | Department of Neurology | ||||||
| Zip code | |||||||
| Address | 2-1-1 Hongo, Bukyo-ku, Tokyo | ||||||
| TEL | 03-3813-3111 | ||||||
| kazuo-y@juntendo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Juntendo University School of Medicine | ||||||
| Division name | Department of Neurology | ||||||
| Zip code | |||||||
| Address | 2-1-1 Hongo, Bukyo-ku, Tokyo | ||||||
| TEL | 03-3813-3111 | ||||||
| Homepage URL | |||||||
| kazuo-y@juntendo.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Neurology, Juntendo University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Neurology, Juntendo University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 順天堂大学医学部付属順天堂医院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000028843 |